Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Legionella Testing Market, by Type
1.4.2 North America Legionella Testing Market, by End-User
1.4.3 North America Legionella Testing Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Forces Analysis
Chapter 4. North America Legionella Testing Market, by Type
4.1 North America Polymerase Chain Reaction (PCR) Market, by Country
4.2 North America Culture Media Market, by Country
4.3 North America Urine Antigen Testing (UAT) Market, by Country
4.4 North America Serology Market, by Country
4.5 North America Direct Fluorescent Antibody (DFA) Test Market, by Country
Chapter 5. North America Legionella Testing Market, by End-User
5.1 North America Clinical Laboratories Market, by Country
5.2 North America Hospitals & Clinics Market, by Country
5.3 North America Others Market, by Country
Chapter 6. North America Legionella Testing Market, by Country
6.1 US Legionella Testing Market
6.1.1 US Legionella Testing Market, by Type
6.1.2 US Legionella Testing Market, by End-User
6.2 Canada Legionella Testing Market
6.2.1 Canada Legionella Testing Market, by Type
6.2.2 Canada Legionella Testing Market, by End-User
6.3 Mexico Legionella Testing Market
6.3.1 Mexico Legionella Testing Market, by Type
6.3.2 Mexico Legionella Testing Market, by End-User
6.4 Rest of North America Legionella Testing Market
6.4.1 Rest of North America Legionella Testing Market, by Type
6.4.2 Rest of North America Legionella Testing Market, by End-User
Chapter 7. Company Profiles
7.1 QuidelOrtho Corporation
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Regional Analysis
7.1.4 Research & Development Expense
7.2 Abbott Laboratories
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 SWOT Analysis
7.3 Merck KGaA
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 SWOT Analysis
7.4 Thermo Fisher Scientific, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 SWOT Analysis
7.5 Bio-Rad laboratories, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 SWOT Analysis
7.6 Becton, Dickinson, and Company
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 SWOT Analysis
7.7 BioMerieux S.A.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.7.5 SWOT Analysis
7.8 IDEXX Laboratories, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expenses
7.8.5 Recent strategies and developments:
7.8.5.1 Acquisition and Mergers:
7.8.6 SWOT Analysis
7.9 Eurofins Scientific SE
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.9.4 SWOT Analysis
7.10. Qiagen N.V.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Regional Analysis
7.10.4 Research & Development Expense
7.10.5 SWOT Analysis
Unique Offerings 